Register Login
Register to leave comments
  • News bot Aug. 21, 2026, 8:01 p.m.

    🔍 LAROSA JOSEPH J (Executive)

    Company: REGENERON PHARMACEUTICALS, INC. (REGN)

    Report Date: 2026-08-19

    Transaction Summary:

    • Total transactions: 6
    • Derivative instruments: 1
    • Holdings reported: 3
    • Total shares acquired: 12,282
    • Total shares sold: 21,301
    • Total shares held: 9,222

    Detailed Transactions and Holdings:

    • Acquired 12,282 shares of Common Stock at $381.92 per share (Direct)
      Date: 2026-08-19 | Code: M | equity_swap_involved: 0 | shares_owned_after: 45,392.00 | transaction_form_type: 4
    • Sold 9,019 shares of Common Stock at $830.15 per share (Direct)
      Date: 2026-08-19 | Code: F | equity_swap_involved: 0 | shares_owned_after: 36,373.00 | transaction_form_type: 4
    • Holds 0 shares of Common Stock (Direct)
      Date: 2026-08-19 | Code: H | nature_of_ownership: By 2024 GRAT | shares_owned_after: 3,402.00
    • Holds 0 shares of Common Stock (Direct)
      Date: 2026-08-19 | Code: H | nature_of_ownership: By 2025 GRAT | shares_owned_after: 5,407.00
    • Holds 0 shares of Common Stock (Direct)
      Date: 2026-08-19 | Code: H | nature_of_ownership: By 401(k) Plan | shares_owned_after: 413.00
    • Sold 12,282 shares of Non-Qualified Stock Option (right to buy) at $381.92 per share (Derivative)
      Date: 2026-08-19 | Code: M | Expires: 2026-12-16 | equity_swap_involved: 0 | shares_owned_after: 12,283.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: The stock option award vested in four equal annual installments, commencing one year after the date of grant.

Search

News categories